The impact of hyperfiltration on the diabetic kidney

Diabetes and Metabolism

Volumn 41, Issue 1, 2015, Pages 5-17

  Premaratne, E ^a   Verma, S ^a   Ekinci, E I ^a,b   Theverkalam, G ^a   Jerums, G ^a   MacIsaac, R J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Menzies School of Medical Research   (Australia)

Author keywords

Diabetic kidney disease; Diabetic nephropathy; Hyperfiltration; Metabolic syndrome; Obesity; Vascular disease

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; C PEPTIDE; CYCLOOXYGENASE 2 INHIBITOR; RUBOXISTAURIN; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR;

ALBUMINURIA; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; DIABETES MELLITUS; DIABETIC KIDNEY DISEASE; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; GLOMERULAR DYSFUNCTION; GLOMERULAR HYPERFILTRATION; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; KIDNEY BLOOD FLOW; KIDNEY DENERVATION; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY PERFUSION; KIDNEY PROXIMAL TUBULE; KIDNEY SIZE; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE PRESSURE; MACROALBUMINURIA; METABOLIC SYNDROME X; NEPHROMEGALY; NEPHRON; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL SYMPATHETIC DENERVATION; REVIEW; RISK REDUCTION; VASCULAR DISEASE; DIABETIC NEPHROPATHY; KIDNEY;

DIABETIC NEPHROPATHIES; HUMANS; KIDNEY; METABOLIC SYNDROME X; OBESITY;

EID: 84921772366     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2014.10.003     Document Type: Review

References (118)

1. Mogensen C.E. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 1999, 42:263-285.
2. Pecly I.M., Genelhu V., Francischetti E.A. Renal functional reserve in obesity hypertension. Int J Clin Pract 2006, 60:1198-1203.
3. Jerums G., Premaratne E., Panagiotopoulos S., MacIsaac R.J. The clinical significance of hyperfiltration in diabetes. Diabetologia 2010, 53:2093-2104.
4. Camargo E.G., Soares A.A., Detanico A.B., Weinert L.S., Veronese F.V., Gomes E.C., et al. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is less accurate in patients with Type 2 diabetes when compared with healthy individuals. Diabet Med 2011, 28:90-95.
5. Maple-Brown L.J., Ekinci E.I., Hughes J.T., Chatfield M., Lawton P.D., Jones G.R., et al. Performance of formulas for estimating glomerular filtration rate in Indigenous Australians with and without Type 2 diabetes: the eGFR Study. Diabet Med 2014, 31:829-838.
6. Gaspari F., Ruggenenti P., Porrini E., Motterlini N., Cannata A., Carrara F., et al. The GFR and GFR decline cannot be accurately estimated in type 2 diabetics. Kidney Int 2013, 84:164-173.
7. MacIsaac R.J., Premaratne E., Jerums G. Estimating glomerular filtration rate in diabetes using serum cystatin C. Clin Biochem Rev 2011, 32:61-67.
8. Premaratne E., MacIsaac R.J., Finch S., Panagiotopoulos S., Ekinci E., Jerums G. Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes. Diabetes Care 2008, 31:971-973.
9. Perkins B.A., Nelson R.G., Ostrander B.E., Blouch K.L., Krolewski A.S., Myers B.D., et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol 2005, 16:1404-1412.
10. Cotroneo P., Manto A., Todaro L., Manto A., Pitocco D., Saponara C., et al. Hyperfiltration in patients with type I diabetes mellitus: a prevalence study. Clin Nephrol 1998, 50:214-217.
11. Dahlquist G., Stattin E.L., Rudberg S. Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients. Nephrol Dial Transplant 2001, 16:1382-1386.
12. Amin R., Turner C., van Aken S., Bahu T.K., Watts A., Lindsell D.R., et al. The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: the Oxford Regional Prospective Study. Kidney Int 2005, 68:1740-1749.
13. Vervoort G., Veldman B., Berden J.H., Smits P., Wetzels J.F. Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion. Eur J Clin Invest 2005, 35:330-336.
14. Ficociello L.H., Perkins B.A., Roshan B., Weinberg J.M., Aschengrau A., Warram J.H., et al. Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care 2009, 32:889-893.
15. Magee G.M., Bilous R.W., Cardwell C.R., Hunter S.J., Kee F., Fogarty D.G. Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 2009, 52:691-697.
16. Thomas M.C., Moran J.L., Harjutsalo V., Thorn L., Waden J., Saraheimo M., et al. Hyperfiltration in type 1 diabetes: does it exist and does it matter for nephropathy?. Diabetologia 2012, 55:1505-1513.
17. Bulum T., Kolaric B., Prkacin I., Duvnjak L. Hyperfiltration in normoalbuminuric type 1 diabetic patients: relationship with urinary albumin excretion rate. Coll Antropol 2013, 37:471-476.
18. Lebovitz H.E., Palmisano J. Cross-sectional analysis of renal function in black Americans with NIDDM. Diabetes Care 1990, 13:1186-1190.
19. Vora J.P., Dolben J., Dean J.D., Thomas D., Williams J.D., Owens D.R., et al. Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int 1992, 41:829-835.
20. Gragnoli G., Signorini A.M., Tanganelli I., Fondelli C., Borgogni P., Borgogni L., et al. Prevalence of glomerular hyperfiltration and nephromegaly in normo- and microalbuminuric type 2 diabetic patients. Nephron 1993, 65:206-211.
21. Silveiro S.P., Friedman R., Gross J.L. Glomerular hyperfiltration in NIDDM patients without overt proteinuria. Diabetes Care 1993, 16:115-119.
22. Bruce R., Rutland M., Cundy T. Glomerular hyperfiltration in young Polynesians with type 2 diabetes. Diabetes Res Clin Pract 1994, 25:155-160.
23. Lee K.U., Park J.Y., Hwang I.R., Hong S.K., Kim G.S., Moon D.H., et al. Glomerular hyperfiltration in Koreans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis 1995, 26:722-726.
24. Keller C.K., Bergis K.H., Fliser D., Ritz E. Renal findings in patients with short-term type 2 diabetes. J Am Soc Nephrol 1996, 7:2627-2635.
25. Vedel P., Obel J., Nielsen F.S., Bang L.E., Svendsen T.L., Pedersen O.B., et al. Glomerular hyperfiltration in microalbuminuric NIDDM patients. Diabetologia 1996, 39:1584-1589.
26. Chaiken R.L., Eckert-Norton M., Bard M., Banerji M.A., Palmisano J., Sachimechi I., et al. Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data. Diabetes Care 1998, 21:2129-2134.
27. Guizar J.M., Kornhauser C., Malacara J.M., Amador N., Barrera J.A., Esparza R. Renal functional reserve in patients with recently diagnosed Type 2 diabetes mellitus with and without microalbuminuria. Nephron 2001, 87:223-230.
28. Ruggenenti P., Porrini E.L., Gaspari F., Motterlini N., Cannata A., Carrara F., et al. Glomerular hyperfiltration and renal disease progression in type 2 diabetes. Diabetes Care 2012, 35:2061-2068.
29. Hostetter T.H. Diabetic nephropathy. Metabolic versus hemodynamic considerations. Diabetes Care 1992, 15:1205-1215.
30. Brenner B.M., Lawler E.V., Mackenzie H.S. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 1996, 49:1774-1777.
31. Sochett E.B., Cherney D.Z., Curtis J.R., Dekker M.G., Scholey J.W., Miller J.A. Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes. J Am Soc Nephrol 2006, 17:1703-1709.
32. Yang G.K., Maahs D.M., Perkins B.A., Cherney D.Z. Renal hyperfiltration and systemic blood pressure in patients with uncomplicated type 1 diabetes mellitus. PLoS One 2013, 8:e68908.
33. Price D.A., Porter L.E., Gordon M., Fisher N.D., De'Oliveira J.M., Laffel L.M., et al. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 1999, 10:2382-2391.
34. Tikellis C., Brown R., Head G.A., Cooper M.E., Thomas M.C. Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes. Am J Physiol Renal Physiol 2014, 306:F773-F780.
35. Chiarelli F., Cipollone F., Romano F., Tumini S., Costantini F., di Ricco L., et al. Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relationo glomerular hyperfiltration. Diabetes 2000, 49:1258-1263.
36. Bank N., Aynedjian H.S. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 1993, 43:1306-1312.
37. Cherney D.Z., Reich H.N., Jiang S., Har R., Nasrallah R., Hebert R.L., et al. Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 2012, 303:R710-R718.
38. Cherney D.Z., Miller J.A., Scholey J.W., Nasrallah R., Hebert R.L., Dekker M.G., et al. Renal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1 diabetes. Diabetes Care 2010, 33:1344-1346.
39. Sasson A.N., Cherney D.Z. Renal hyperfiltration related to diabetes mellitus and obesity in human disease. World J Diabetes 2012, 3:1-6.
40. Vallon V., Richter K., Blantz R.C., Thomson S., Osswald H. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 1999, 10:2569-2576.
41. Yang G.K., Har R.L., Lytvyn Y., Yip P., Cherney D.Z. Renal hyperfiltration is associated with glucose-dependent changes in fractional excretion of sodium in patients with uncomplicated Type 1 diabetes. Diabetes Care 2014, [In press].
42. Sallstrom J., Carlsson P.O., Fredholm B.B., Larsson E., Persson A.E., Palm F. Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism. Acta Physiol (Oxf) 2007, 190:253-259.
43. Persson P., Hansell P., Palm F. Tubular reabsorption and diabetes-induced glomerular hyperfiltration. Acta Physiol (Oxf) 2010, 200:3-10.
44. Cherney D.Z., Miller J.A., Scholey J.W., Bradley T.J., Slorach C., Curtis J.R., et al. The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes. Diabetes 2008, 57:688-695.
45. Cherney D.Z., Sochett E.B., Dekker M.G., Perkins B.A. Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes. Diabet Med 2010, 27:1358-1365.
46. Mogensen C.E., Andersen M.J. Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: normalization by insulin-treatment. Diabetologia 1975, 11:221-224.
47. Woods L.L., Mizelle H.L., Hall J.E. Control of renal hemodynamics in hyperglycemia: possible role of tubuloglomerular feedback. Am J Physiol 1987, 252:F65-F73.
48. Cooper M.E. Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 2001, 44:1957-1972.
49. Webb R.C., Bohr D.F. Recent advances in the pathogenesis of hypertension: consideration of structural, functional, and metabolic vascular abnormalities resulting in elevated arterial resistance. Am Heart J 1981, 102:251-264.
50. Drummond K., Mauer M. International Diabetic Nephropathy Study. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 2002, 51:1580-1587.
51. Hernandez-Marco R., Codoner-Franch P., Pons Morales S., Del Castillo Villaescusa C., Boix Garcia L., Valls Belles V. Oxidant/antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus. Pediatr Nephrol 2009, 24:121-127.
52. Har R., Scholey J.W., Daneman D., Mahmud F.H., Dekker R., Lai V., et al. The effect of renal hyperfiltration on urinary inflammatory cytokines/chemokines in patients with uncomplicated type 1 diabetes mellitus. Diabetologia 2013, 56:1166-1173.
53. Pecis M., Azevedo M.J., Gross J.L. Glomerular hyperfiltration is associated with blood pressure abnormalities in normotensive normoalbuminuric IDDM patients. Diabetes Care 1997, 20:1329-1333.
54. Cherney D.Z., Sochett E.B., Lai V., Dekker M.G., Slorach C., Scholey J.W., et al. Renal hyperfiltration and arterial stiffness in humans with uncomplicated type 1 diabetes. Diabetes Care 2010, 33:2068-2070.
55. Brenner B.M. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983, 23:647-655.
56. Zatz R., Meyer T.W., Rennke H.G., Brenner B.M. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A 1985, 82:5963-5967.
57. Hostetter T.H., Olson J.L., Rennke H.G., Venkatachalam M.A., Brenner B.M. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981, 241:F85-F93.
58. Walker J.D., Bending J.J., Dodds R.A., Mattock M.B., Murrells T.J., Keen H., et al. Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet 1989, 2:1411-1415.
59. Zeller K., Whittaker E., Sullivan L., Raskin P., Jacobson H.R. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 1991, 324:78-84.
60. Hirose K., Tsuchida H., Osterby R., Gundersen H.J. A strong correlation between glomerular filtration rate and filtration surface in diabetic kidney hyperfunction. Lab Invest 1980, 43:434-437.
61. Wiseman M.J., Saunders A.J., Keen H., Viberti G. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 1985, 312:617-621.
62. Mauer S.M., Steffes M.W., Ellis E.N., Sutherland D.E., Brown D.M., Goetz F.C. Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984, 74:1143-1155.
63. Osterby R. Early phases in the development of diabetic glomerulopathy. Acta Med Scand Suppl 1974, 574:3-82.
64. Thomson S.C., Deng A., Bao D., Satriano J., Blantz R.C., Vallon V. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest 2001, 107:217-224.
65. Mogensen C.E., Andersen M.J. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 1973, 22:706-712.
66. Hostetter T.H. Hypertrophy and hyperfunction of the diabetic kidney. J Clin Invest 2001, 107:161-162.
67. Bak M., Thomsen K., Christiansen T., Flyvbjerg A. Renal enlargement precedes renal hyperfiltration in early experimental diabetes in rats. J Am Soc Nephrol 2000, 11:1287-1292.
68. Vallon V., Rose M., Gerasimova M., Satriano J., Platt K.A., Koepsell H., et al. Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. Am J Physiol Renal Physiol 2013, 304:F156-F167.
69. Lawson M.L., Sochett E.B., Chait P.G., Balfe J.W., Daneman D. Effect of puberty on markers of glomerular hypertrophy and hypertension in IDDM. Diabetes 1996, 45:51-55.
70. Zerbini G., Bonfanti R., Meschi F., Bognetti E., Paesano P.L., Gianolli L., et al. Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes. Diabetes 2006, 55:2620-2625.
71. Rigalleau V., Garcia M., Lasseur C., Laurent F., Montaudon M., Raffaitin C., et al. Large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease. BMC Nephrol 2010, 11:3.
72. Rudberg S., Osterby R. Decreasing glomerular filtration rate--an indicator of more advanced diabetic glomerulopathy in the early course of microalbuminuria in IDDM adolescents?. Nephrol Dial Transplant 1997, 12:1149-1154.
73. Yip J.W., Jones S.L., Wiseman M.J., Hill C., Viberti G. Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study. Diabetes 1996, 45:1729-1733.
74. Perkins B.A., Ficociello L.H., Ostrander B.E., Silva K.H., Weinberg J., Warram J.H., et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol 2007, 18:1353-1361.
75. Silveiro S.P., Friedman R., de Azevedo M.J., Canani L.H., Gross J.L. Five-year prospective study of glomerular filtration rate and albumin excretion rate in normofiltering and hyperfiltering normoalbuminuric NIDDM patients. Diabetes Care 1996, 19:171-174.
76. Rius F., Pizaro E., Salinas I., Lucas A., Sanmarti A., Romero R. Age as a determinant of glomerular filtration rate in non-insulin-dependent diabetes mellitus. Nephrol Dial Transplant 1995, 10:1644-1647.
77. Premaratne E., MacIsaac R.J., Tsalamandris C., Panagiotopoulos S., Smith T., Jerums G. Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate. Diabetologia 2005, 48:2486-2493.
78. Daousi C., Casson I.F., Gill G.V., MacFarlane I.A., Wilding J.P., Pinkney J.H. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgrad Med J 2006, 82:280-284.
79. Maric C., Hall J.E. Obesity, metabolic syndrome and diabetic nephropathy. Contrib Nephrol 2011, 170:28-35.
80. Tomaszewski M., Charchar F.J., Maric C., McClure J., Crawford L., Grzeszczak W., et al. Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int 2007, 71:816-821.
81. Wuerzner G., Pruijm M., Maillard M., Bovet P., Renaud C., Burnier M., et al. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am J Kidney Dis 2010, 56:303-312.
82. Chagnac A., Herman M., Zingerman B., Erman A., Rozen-Zvi B., Hirsh J., et al. Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant 2008, 23:3946-3952.
83. Kwakernaak A.J., Toering T.J., Navis G. Body mass index and body fat distribution as renal risk factors: a focus on the role of renal haemodynamics. Nephrol Dial Transplant 2013, 28(Suppl. 4):iv42-iv49.
84. Jaffa A.A., LeRoith D., Roberts C.T., Rust P.F., Mayfield R.K. Insulin-like growth factor I produces renal hyperfiltration by a kinin-mediated mechanism. Am J Physiol 1994, 266:F102-F107.
85. Wolf G., Chen S., Han D.C., Ziyadeh F.N. Leptin and renal disease. Am J Kidney Dis 2002, 39:1-11.
86. Kielstein J.T., Becker B., Graf S., Brabant G., Haller H., Fliser D. Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am J Kidney Dis 2003, 42:62-66.
87. Schalkwijk C.G., Chaturvedi N., Schram M.T., Fuller J.H., Stehouwer C.D. Adiponectin is inversely associated with renal function in type 1 diabetic patients. J Clin Endocrinol Metab 2006, 91:129-135. Group EPCS.
88. Papafragkaki D.K., Tolis G. Obesity and renal disease: a possible role of leptin. Hormones (Athens) 2005, 4:90-95.
89. Wei P., Lane P.H., Lane J.T., Padanilam B.J., Sansom S.C. Glomerular structural and functional changes in a high-fat diet mouse model of early-stage Type 2 diabetes. Diabetologia 2004, 47:1541-1549.
90. Wu Y., Liu Z., Xiang Z., Zeng C., Chen Z., Ma X., et al. Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology 2006, 147:44-50.
91. Torbjornsdotter T.B., Jaremko G.A., Berg U.B. Nondipping and its relation to glomerulopathy and hyperfiltration in adolescents with type 1 diabetes. Diabetes Care 2004, 27:510-516.
92. Groop P.H., Thomas M.C., Moran J.L., Waden J., Thorn L.M., Makinen V.P., et al. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 2009, 58:1651-1658.
93. Fox C.S., Matsushita K., Woodward M., Bilo H.J., Chalmers J., Heerspink H.J., et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 2012, 380:1662-1673.
94. Eriksen B.O., Lochen M.L., Arntzen K.A., Bertelsen G., Eilertsen B.A., von Hanno T., et al. Subclinical cardiovascular disease is associated with a high glomerular filtration rate in the nondiabetic general population. Kidney Int 2014, 86:146-153.
95. Rognant N., Laville M. To live with normal GFR: when higher is not better. Kidney Int 2014, 86:10-13.
96. Chagnac A., Weinstein T., Herman M., Hirsh J., Gafter U., Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003, 14:1480-1486.
97. Holtkamp F.A., de Zeeuw D., Thomas M.C., Cooper M.E., de Graeff P.A., Hillege H.J., et al. An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function. Kidney Int 2011, 80:282-287.
98. Pistrosch F., Herbrig K., Kindel B., Passauer J., Fischer S., Gross P. Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients. Diabetes 2005, 54:2206-2211.
99. Cherney D.Z., Perkins B.A., Soleymanlou N., Maione M., Lai V., Lee A., et al. Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus. Circulation 2014, 129:587-597.
100. Nordquist L., Brown R., Fasching A., Persson P., Palm F. Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption. Am J Physiol Renal Physiol 2009, 297:F1265-F1272.
101. Koya D., Haneda M., Nakagawa H., Isshiki K., Sato H., Maeda S., et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 2000, 14:439-447.
102. Luippold G., Beilharz M., Muhlbauer B. Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats. Nephrol Dial Transplant 2004, 19:342-347.
103. Kinebuchi S., Kazama J.J., Satoh M., Sakai K., Nakayama H., Yoshizawa H., et al. Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome. Clin Sci (Lond) 2004, 107:317-322.
104. Cherney D.Z., Scholey J.W., Jiang S., Har R., Lai V., Sochett E.B., et al. The effect of direct renin inhibition alone and in combination with ACE inhibition on endothelial function, arterial stiffness, and renal function in type 1 diabetes. Diabetes Care 2012, 35:2324-2330.
105. Parving H.H., Persson F., Lewis J.B., Lewis E.J., Hollenberg N.K. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med 2008, 358:2433-2446.
106. Cherney D.Z., Konvalinka A., Zinman B., Diamandis E.P., Soosaipillai A., Reich H., et al. Effect of protein kinase C beta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study. Diabetes Care 2009, 32:91-93.
107. Layton D., Souverein P.C., Heerdink E.R., Shakir S.A., Egberts A.C. Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands. Drug Saf 2008, 31:143-158.
108. Nordquist L., Wahren J. C-Peptide: the missing link in diabetic nephropathy?. Rev Diabet Stud 2009, 6:203-210.
109. Foote C., Perkovic V., Neal B. Effects of SGLT2 inhibitors on cardiovascular outcomes. Diab Vasc Dis Res 2012, 9:117-123.
110. Lervang H.H., Jensen S., Brochner-Mortensen J., Ditzel J. Early glomerular hyperfiltration and the development of late nephropathy in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1988, 31:723-729.
111. Azevedo M.J., Gross J.L. Follow-up of glomerular hyperfiltration in normoalbuminuric type 1 (insulin-dependent) diabetic patients. Diabetologia 1991, 34:611.
112. Jones S.L., Wiseman M.J., Viberti G.C. Glomerular hyperfiltration as a risk factor for diabetic nephropathy: five-year report of a prospective study. Diabetologia 1991, 34:59-60.
113. Caramori M.L., Gross J.L., Pecis M., de Azevedo M.J. Glomerular filtration rate, urinary albumin excretion rate, and blood pressure changes in normoalbuminuric normotensive type 1 diabetic patients: an 8-year follow-up study. Diabetes Care 1999, 22:1512-1516.
114. Mogensen C.E., Christensen C.K. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984, 311:89-93.
115. Mogensen C.E. Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 1986, 46:201-206.
116. Rudberg S., Persson B., Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy--an 8-year prospective study. Kidney Int 1992, 41:822-828.
117. Lervang H.H., Jensen S., Brochner-Mortensen J., Ditzel J. Does increased glomerular filtration rate or disturbed tubular function early in the course of childhood type 1 diabetes predict the development of nephropathy?. Diabet Med 1992, 9:635-640.
118. Chiarelli F., Verrotti A., Morgese G. Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children. Pediatr Nephrol 1995, 9:154-158.